Roberts Zachary (CIK 1851044) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-04). Recent activity: Sell ALLO (35,700 shares), Sell ALLO (26,269 shares), Sell ALLO (18,832 shares), Buy ALLO (173,913 shares), Sell ALLO (27,199 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-04 | Allogene Therapeutics, Inc. (ALLO) | EVP of R&D | Sell | 35,700 | $63,189 |
| 2026-01-23 | Allogene Therapeutics, Inc. (ALLO) | EVP of R&D | Sell | 26,269 | $40,980 |
| 2025-02-05 | Allogene Therapeutics, Inc. (ALLO) | EVP of R&D | Sell | 18,832 | $32,014 |
| 2025-01-28 | Allogene Therapeutics, Inc. (ALLO) | EVP of R&D | Buy | 173,913 | $0 |
| 2025-01-23 | Allogene Therapeutics, Inc. (ALLO) | EVP of R&D | Sell | 27,199 | $48,414 |
Source: SEC Form 4 filings · as of 2026-02-04